Is it time to screen for adult coeliac disease?

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 10, 2011, Pages 833-838

  Evans, Kate Emma ^a   Hadjivassiliou, Marios ^a   Sanders, David S ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

coeliac disease; cost effectiveness; gluten; screening

Indexed keywords

ENDOMYSIUM ANTIBODY; HLA ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ABDOMINAL PAIN; ATAXIA; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; BIRTH RATE; BODY MASS; BONE DENSITY; BREAST CANCER; CANCER RISK; CASE FINDING; CELIAC DISEASE; CLINICAL FEATURE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DELAYED DIAGNOSIS; DIARRHEA; DOWN SYNDROME; DUODENUM BIOPSY; EARLY DIAGNOSIS; FATIGUE; FRACTURE; GASTROINTESTINAL SYMPTOM; GASTROSCOPY; GLUTEN FREE DIET; HEALTH CARE COST; HUMAN; INFANT FEEDING; INFERTILITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; INTRAUTERINE GROWTH RETARDATION; LATENT PERIOD; LOW BIRTH WEIGHT; LUNG CANCER; LYMPHOCYTE; MASS SCREENING; MORBIDITY; MORTALITY; NEOPLASM; NONHODGKIN LYMPHOMA; OBESITY; OSTEOPOROSIS; PATIENT COMPLIANCE; PREDICTIVE VALUE; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SERODIAGNOSIS; WEIGHT GAIN; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

ADULT; CELIAC DISEASE; COST-BENEFIT ANALYSIS; DIET, GLUTEN-FREE; FEMALE; HUMANS; MALE; MASS SCREENING; PREVALENCE;

EID: 80052675541     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328348f9aa     Document Type: Review

References (64)

1. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO; 1968.
2. Catassi C, Rätsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343:200-203.
3. Simell S, Hoppu S, Hekkala A, Simell T, Sta°hlberg MR, Viander M, et al. Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. Am J Gastroenterol 2007; 102:2026-2035. (Pubitemid 47301530)
4. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009; 137:88-93.
5. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp SL, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 2010; 42:530-8.
6. Mariné M, Fernández-Bañares F, Alsina M, Farré C, Cortijo M, Santaolalla R, et al. Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol 2009; 15:1331-1338.
7. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, et al. Seroprevalence correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52:960-965. (Pubitemid 36765286)
8. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007; 26:1217-1225. (Pubitemid 47620425)
9. Van Heel DA, West J. Recent advances in coeliac disease. Gut 2006; 55:1037-1046. (Pubitemid 43962618)
10. Bingley P, Williams AJ, Norcross AJ, Unsworth DJ, Lock RJ, Ness AR, et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 2004; 328:322-323. (Pubitemid 38197849)
11. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 2000; 356:1494-1495.
12. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 2006; 91:39-43. (Pubitemid 43059171)
13. Sepp E, Julge K, Vasar M, Naaber P, Björksten B, Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 1997; 86: 956-961. (Pubitemid 27425591)
14. Collin P, Kaukinen K, Välimäki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23:464-483.
15. Counsell CE, Ruddell WS. Association between coeliac disease and autoimmune thyroid disease. Gut 1995; 36:475-476.
16. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163:286-292. (Pubitemid 36183856)
17. Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005; 128((4 Suppl 1)):S57-S67. (Pubitemid 40460823)
18. Cronin CC, Feighery A, Ferriss JB, Liddy C, Shanahan F, Feighery C. High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol 1997; 92:2210-2212.
19. Sjö berg K, Eriksson KF, Bredberg A,Wassmuth R, Eriksson S. Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med 1998; 243:133-140. (Pubitemid 28156661)
20. Carlsson A, Axelsson I, Borulf S, Bredberg A, Forslund M, Lindberg B, et al. Prevalence of IgA-antigliadin antibodies and IgA-antiendomysium antibodies related to celiac disease in children with Down syndrome. Pediatrics 1998; 101:272-275. (Pubitemid 28076663)
21. Gale L, Wimalaratna H, Brotodiharjo A, Duggan JM. Down's syndrome is strongly associated with coeliac disease. Gut 1997; 40:492-496. (Pubitemid 27204929)
22. Bushara KO. Neurologic presentation of celiac disease. Gastroenterology 2005; 128(4 Suppl 1):S92-S97. (Pubitemid 40460828)
23. Richey R, Howdle P, Shaw E, Stokes TGuideline Development Group. Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance. BMJ 2009; 338:b1684.
24. Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006; 38:374-380. (Pubitemid 44356222)
25. Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005; 128(4 Suppl):S57-S67. (Pubitemid 40460823)
26. Cheng J, Brar PS, Lee AR, Green PH. Body mass index in celiac disease: beneficial effect of a gluten-free diet. J Clin Gastroenterol 2010; 44:267-271.
27. Cranney A, Zarkadas M, Graham ID, Butzner JD, Rashid M, Warren R, et al. The Canadian Celiac Health Survey. Dig Dis Sci 2007; 52:1087-1095. (Pubitemid 46481243)
28. Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, Egner W, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol 2008; 6:314-320. (Pubitemid 351318379)
29. Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128:S38-S46. (Pubitemid 40460820)
30. Lähdeaho ML, Kaukinen K, Collin P, Ruuska T, Partanen J, Haapala AM, et al. Celiac disease: from inflammation to atrophy: a long-term follow-up study. J Pediatr Gastroenterol Nutr 2005; 41:44-48. (Pubitemid 40967354)
31. Shamir R, Yehezkely-Schildkraut V, Hartman C, Eliakim R. Population screening for celiac disease: follow up of patients identified by positive serology. J Gastroenterol Hepatol 2007; 22:532-535. (Pubitemid 46434980)
32. Hadithi M, Von Blomberg BM, Crusius JB, Bloemena E, Kostense PJ, Meijer JW, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007; 147:294-302. (Pubitemid 351664556)
33. Bourgey M, Calcagno G,Tinto N, Gennarelli D, Margaritte-Jeannin P, Greco L, et al. HLA related genetic risk for coeliac disease. Gut 2007; 56:1054-1059. (Pubitemid 47123232)
34. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358:356-361. (Pubitemid 32739095)
35. Leffler DA, Edwards-George J, Dennis M, Schuppan D, Cook F, Franko DL, et al. Factors that influence adherence to a gluten-free diet in adults with celiac disease. Dig Dis Sci 2008; 53:1573-1581.
36. Nachman F, Mauriño E, Vázquez H, Sfoggia C, Gonzalez A, Gonzalez V, et al. Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis 2009; 41:15-25.
37. Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009; 30:315-330.
38. Tursi A, Elisei W, Giorgetti GM, Brandimarte G, Aiello F. Complications in celiac disease under gluten-free diet. Dig Dis Sci 2009; 54:2175-2182.
39. Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009; 302:1171-1178.
40. Lohi S, Mäki M, Rissanen H, Knekt P, Reunanen A, Kaukinen K. Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med 2009; 41:508-515.
41. Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH. Coeliac disease detected by screening is not silent: simply unrecognized. QJM 1998; 91:853-860. (Pubitemid 29027072)
42. Metzger MH, Heier M, Mäki M, Bravi E, Schneider A, Löwel H, et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol 2006; 21:359-365. (Pubitemid 44050805)
43. Godfrey JD, Brantner TL, Brinjikji W, Christensen KN, Brogan DL, Van Dyke CT, et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010; 139:763-769.
44. Ciacci C, Cirillo M, Auriemma G, Di Dato G, Sabbatini F, Mazzacca G. Celiac disease and pregnancy outcome. Am J Gastroenterol 1996; 91:718-722. (Pubitemid 26117950)
45. Ludvigsson JF, Montgomery SM, Ekbom A. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology 2005; 129:454-463. (Pubitemid 41096633)
46. Greco L, Veneziano A, Di Donato L, Zampella C, Pecoraro M, Paladini D, et al. Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut 2004; 53:149-151. (Pubitemid 38083024)
47. Meyer D, Stavropolous S, Diamond B, Shane E, Green PH. Osteoporosis in a North American adult population with celiac disease. Am J. Gastroenterol 2001; 96:112-119. (Pubitemid 32104817)
48. Corazza GR, Di Sario A, Cecchetti L, Jorizzo RA, Di Stefano M, Minguzzi L, et al. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone 1996; 18: 525-530. (Pubitemid 26257872)
49. Cellier C, Flobert C, Cormier C, Roux C, Schmitz J. Severe osteopenia in symptom-free adults with a childhood diagnosis of coeliac disease. Lancet 2000; 355:806. (Pubitemid 30128823)
50. West J, Logan RF, Card TR, Smith C, Hubbard R. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 2003; 125:429-436. (Pubitemid 36929424)
51. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004; 20:769-775. (Pubitemid 39319232)
52. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 2004; 329:716-719.
53. Logan RF. Malignancy in unrecognised coeliac disease: a nail in the coffin for mass screening? Gut 2009; 58:618-619.
54. Lohi S, Mäki M, Montonen J, Knekt P, Pukkala E, Reunanen A, et al. Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut 2009; 58:643-647.
55. Shamir R, Hernell O, Leshno M. Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making 2006; 26:282-293. (Pubitemid 43726014)
56. Mein SM, Ladabaum U. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Aliment Pharmacol Ther 2004; 19:1199-1210. (Pubitemid 38746263)
57. Dorn SD, Matchar DB. Cost-effectiveness analysis of strategies for diagnosing celiac disease. Dig Dis Sci 2008; 53:680-688. (Pubitemid 351317092)
58. Green PH, Neugut AI, Naiyer AJ, Edwards ZC, Gabinelle S, Chinburapa V. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. J Insur Med 2008; 40:218-228.
59. Long KH, Rubio-Tapia A, Wagie AE, Melton LJ 3rd, Lahr BD, Van Dyke CT, et al. The economics of coeliac disease: a population-based study. Aliment Pharmacol Ther 2010; 32:261-269.
60. Gray AM, Papanicolas IN. Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res 2010; 10:105.
61. Mayor S. UK deaths from breast cancer fall to lowest figure for 40 years. BMJ 2009; 338:b1710.
62. Jørgensen KJ, Brodersen J, Nielsen M, Hartling OJ, Gøtzsche PC. Fall in breast cancer deaths. A cause for celebration, and caution. BMJ 2009; 338:b2126.
63. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009; CD001877.
64. Gøtzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jørgensen KJ. Breast screening: the facts-or maybe not. BMJ 2009; 338:b86.